Endpoints News
Pfizer’s Lyme disease vaccine trial hampered by lack of cases
Pfizer’s final-stage trial of its long-awaited Lyme disease vaccine missed its primary endpoint, but the drugmaker said it still plans to try to take the experimental shot to regulators for approval.
The company said there …